SGBI — Sangui Biotech International Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Sangui Biotech International, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.216 | -0.343 | -0.199 | -0.204 | -0.063 |
| Depreciation | |||||
| Non-Cash Items | 0 | 0.012 | -0.009 | 0.015 | -0.113 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.038 | 0.014 | 0.038 | 0.042 | 0.035 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.254 | -0.317 | -0.168 | -0.146 | -0.14 |
| Capital Expenditures | — | — | -0.003 | 0 | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | — | -0.003 | 0 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.245 | 0.327 | 0.159 | 0.162 | 0.142 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.036 | 0.007 | -0.012 | 0.014 | 0.001 |